Publication | Closed Access

Fraxin Alleviates LPS-Induced ARDS by Downregulating Inflammatory Responses and Oxidative Damages and Reducing Pulmonary Vascular Permeability

InflammationInflammatory ResponsesOxidative DamagesPulmonary Arterial HypertensionPulmonary CirculationInflammatory Lung DiseaseLps-induced ArdsLung InflammationMedicineImmunologyPulmonary PharmacologyVascular BiologyPharmacologyPulmonary DiseasePulmonary Vascular DiseaseOxidative Stress